Victory Capital Management
CPIX icon

Victory Capital Management’s Cumberland Pharmaceuticals CPIX Stock Holding History

Victory Capital Management’s Portfolio CPIX Stock Details CPIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,473
Closed -$5K – 2678
2020
Q1 		$5K Buy
+1,473
New +$6.59K ﹤0.01% 3272
2019
Q4 		– Sell
-1,523
Closed -$9K – 2774
2019
Q3 		$9K Buy
+1,523
New +$8.47K ﹤0.01% 3294

Other funds holding CPIX

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Ariel Investments
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Stonepine Capital Management
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bridgeway Capital Management
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Victory Capital Management's CPIX Position: Q2 2020 in Review

Victory Capital Management sold out of Cumberland Pharmaceuticals (CPIX) in Q2 2020, closing a stake of 1,473 shares — an estimated $5K sold.

Victory Capital Management first reported a position in CPIX in Q3 2019 and held it in 2 quarters. The position peaked at $9K in Q3 2019. 30 funds tracked by Wall St. Rank hold CPIX as of Q2 2020.

  • Victory Capital Management reported no remaining Cumberland Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • Victory Capital Management sold 1,473 Cumberland Pharmaceuticals shares in Q2 2020, an estimated $5K.
  • Victory Capital Management first reported a position in Cumberland Pharmaceuticals in Q3 2019 and held it in 2 quarters.
  • Victory Capital Management's Cumberland Pharmaceuticals position peaked at $9K in Q3 2019.
  • 30 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q2 2020.

Based on Victory Capital Management's 13F filing for Q2 2020, filed 7 Aug 2020.